Original Article

You have full text access to this OnlineOpen article

Epidemiology and outcome of infections in human immunodeficiency virus/hepatitis c virus–coinfected liver transplant recipients: A FIPSE/GESIDA Prospective Cohort Study†‡§

  1. Asunción Moreno1,
  2. Carlos Cervera1,
  3. Jesús Fortún2,
  4. Marino Blanes3,
  5. Estibalitz Montejo4,
  6. Manuel Abradelo5,
  7. Oscar Len6,
  8. Antonio Rafecas7,
  9. Pilar Martín-Davila2,
  10. Julián Torre-Cisneros8,
  11. Magdalena Salcedo9,
  12. Elisa Cordero10,
  13. Ricardo Lozano11,
  14. Iñaki Pérez1,
  15. Antonio Rimola1,12,
  16. José M. Miró1,*,
  17. the OLT-HIV FIPSE Cohort Investigators

Article first published online: 21 DEC 2011

DOI: 10.1002/lt.22431

Issue

Liver Transplantation

Liver Transplantation

Volume 18, Issue 1, pages 70–81, January 2012

Additional Information

How to Cite

Moreno, A., Cervera, C., Fortún, J., Blanes, M., Montejo, E., Abradelo, M., Len, O., Rafecas, A., Martín-Davila, P., Torre-Cisneros, J., Salcedo, M., Cordero, E., Lozano, R., Pérez, I., Rimola, A., Miró, J. M. and the OLT-HIV FIPSE Cohort Investigators (2012), Epidemiology and outcome of infections in human immunodeficiency virus/hepatitis c virus–coinfected liver transplant recipients: A FIPSE/GESIDA Prospective Cohort Study. Liver Transpl, 18: 70–81. doi: 10.1002/lt.22431

Author Information

  1. 1

    Hospital Clínic- Institut d'Investigacions Biomèdiques August Pi i Sunyer (IDIBAPS), Universitat de Barcelona, Barcelona

  2. 2

    Hospital Universitario Ramón y Cajal, Madrid

  3. 3

    Hospital Universitario La Fé, Valencia

  4. 4

    Hospital Universitario de Cruces, Bilbao

  5. 5

    Hospital Universitario Doce de Octubre, Madrid

  6. 6

    Hospital Universitario Vall d'Hebrón, Barcelona

  7. 7

    Hospital Universitario de Bellvitge- Institut d' Investigació Biomèdica de Bellvitge (IDIBELL), Hospitalet del Llobregat, Barcelona

  8. 8

    Hospital Universitario Reina Sofía- Instituto Maimónides de Investigación Biomédica de Córdoba (IMIBIC), Córdoba

  9. 9

    Hospital General Universitario Gregorio Marañón, Madrid

  10. 10

    Hospital Universitario Virgen del Rocío, Sevilla

  11. 11

    Hospital Clínico Universitario Lozano Blesa, Zaragoza

  12. 12

    Investigación Biomédica en Red de Enfermedades Hepóticas y Digestivas (CIBERehd), Spain

*Infectious Diseases Service, Villarroel 170, Barcelona, Spain 08036

  1. †

    The results of this article were presented in part at the 49th Annual Interscience Conference on Antimicrobial Agents and Chemotherapy, San Francisco, CA, 2009 (abstract K-974).

  2. ‡

    A list of the investigators is provided in the supporting information.

  3. §

    This study was supported by the Spanish Foundation for the Investigation and Prevention of Acquired Immunodeficiency Syndrome (Madrid, Spain) through research grants TOH-VIH-05 and TOH-VIH-08. José M. Miró received an INT10/219 Intensification Research Grant (through I3SNS and PRICS) from the Carlos III Institute of Health (Madrid, during 2011 Spain) and the Department of Health of the Generalitat of Catalonia (Barcelona, Spain).

Publication History

  1. Issue published online: 21 DEC 2011
  2. Article first published online: 21 DEC 2011
  3. Accepted manuscript online: 6 SEP 2011 02:12PM EST
  4. Manuscript Accepted: 25 AUG 2011
  5. Manuscript Received: 30 MAY 2011

Funded by

  • Spanish Foundation for the Investigation and Prevention of Acquired Immunodeficiency Syndrome (Madrid, Spain). Grant Numbers: TOH-VIH-05, TOH-VIH-08
  • INT10/219 Intensification Research Grant (through I3SNS and PRICS) from the Carlos III Institute of Health (Madrid, during 2011 Spain)
  • Department of Health of the Generalitat of Catalonia (Barcelona, Spain

SEARCH

SEARCH BY CITATION

ARTICLE TOOLS

View Full Article (HTML) Get PDF (492K)

REFERENCES

  • 1
    Fung J, Eghtesad B, Patel-Tom K, DeVera M, Chapman H, Ragni M. Liver transplantation in patients with HIV infection. Liver Transpl 2004; 10( suppl 2): S39-S53.
    Direct Link:
  • 2
    Roland M, Carlson L, Stock P. Solid organ transplantation in HIV-infected individuals. AIDS Clin Care 2002; 14: 59-63.
  • 3
    Ragni MV, Belle SH, Im K, Neff G, Roland M, Stock P, et al. Survival of human immunodeficiency virus-infected liver transplant recipients. J Infect Dis 2003; 188: 1412-1420.
  • 4
    Neff GW, Bonham A, Tzakis AG, Ragni M, Jayaweera D, Schiff ER, et al. Orthotopic liver transplantation in patients with human immunodeficiency virus and end-stage liver disease. Liver Transpl 2003; 9: 239-247.
    Direct Link:
  • 5
    Norris S, Taylor C, Muiesan P, Portmann BC, Knisely AS, Bowles M, et al. Outcomes of liver transplantation in HIV-infected individuals: the impact of HCV and HBV infection. Liver Transpl 2004; 10: 1271-1278.
    Direct Link:
  • 6
    Radecke K, Frühauf NR, Miller M, Ross B, Köditz R, Malagó M, et al. Outcome after orthotopic liver transplantation in five HIV-infected patients with virus hepatitis-induced cirrhosis. Liver Int 2005; 25: 101-108.
    Direct Link:
  • 7
    Vogel M, Voigt E, Schäfer N, Goldmann G, Schwarz N, Kalff JC, et al. Orthotopic liver transplantation in human immunodeficiency virus (HIV)-positive patients: outcome of 7 patients from the Bonn cohort. Liver Transpl 2005; 11: 1515-1521.
    Direct Link:
  • 8
    Duclos-Vallée JC, Féray C, Sebagh M, Teicher E, Roque-Afonso AM, Roche B, et al.; for THEVIC Study Group. Survival and recurrence of hepatitis C after liver transplantation in patients coinfected with human immunodeficiency virus and hepatitis C virus. Hepatology 2008; 47: 407-417.
    Direct Link:
  • 9
    de Vera ME, Dvorchik I, Tom K, Eghtesad B, Thai N, Shakil O, et al. Survival of liver transplant patients coinfected with HIV and HCV is adversely impacted by recurrent hepatitis C. Am J Transplant 2006; 6: 2983-2993.
    Direct Link:
  • 10
    Schreibman I, Gaynor JJ, Jayaweera D, Pyrsopoulos N, Weppler D, Tzakis A, et al. Outcomes after orthotopic liver transplantation in 15 HIV-infected patients. Transplantation 2007; 84: 697-705.
  • 11
    Vennarecci G, Ettorre GM, Antonini M, Santoro R, Perracchio L, Visco G, Santoro E. Liver transplantation in HIV-positive patients. Transplant Proc 2007; 39: 1936-1938.
  • 12
    Roland ME, Stock PG. Review of solid-organ transplantation in HIV-infected patients. Transplantation 2003; 75: 425-429.
  • 13
    Sociedad Española de Trasplante Hepático. Consensus document of the Spanish Society of Liver Transplantation. Waiting lists, liver transplantation and quality indicators [in Spanish]. Gastroenterol Hepatol 2009; 32: 702-716.
  • 14
    Miró JM, Torre-Cisnero J, Moreno A, Tuset M, Quereda C, Laguno M, et al. GESIDA/GESITRA-SEIMC, PNS and ONT consensus document on solid organ transplant (SOT) in HIV-infected patients in Spain (March, 2005) [in Spanish]. Enferm Infecc Microbiol Clin 2005; 23: 353-362.
  • 15
    Feng S, Goodrich NP, Bragg-Gresham JL, Dykstra DM, Punch JD, DebRoy MA, et al. Characteristics associated with liver graft failure: the concept of a donor risk index. Am J Transplant 2006; 6: 783-790.
    Direct Link:
  • 16
    Kamath PS, Wiesner RH, Malinchoc M, Kremers W, Therneau TM, Kosberg CL, D'Amico G, Dickson ER, Kim WR. A model to predict survival in patients with end-stage liver disease. Hepatology 2001;33:464–470.
  • 17
    Iribarren JA, Labarga P, Rubio R, Berenguer J, Miró JM, Antela A, et al.; for Grupo de Estudio de Sida and Consejo Asesor Clínico del Plan Nacional Sobre el Sida del Ministerio de Sanidad y Consumo. Spanish GESIDA/Nacional AIDS Plan recommendations for antiretroviral therapy in HIV-infected adults (October 2004) [in Spanish]. Enferm Infecc Microbiol Clin 2004; 22: 564-642.
  • 18
    Panel de Expertos de Grupo de Estudio del Sida; Plan Nacional Sobre el Sida. 2008 prevention of opportunistic infections in HIV-infected adolescents and adults guidelines. Recommendations of GESIDA/National AIDS Plan AIDS Study Group (GESIDA) and National AIDS Plan [in Spanish]. Enferm Infecc Microbiol Clin 2008; 26: 437-464.
  • 19
    Ayats-Ardite J, Cisneros-Herreros JM, Pérez-Sáenz JL, de la Torre-Cisneros J. Infectious disease assessment in solid organ transplant candidates [in Spanish]. Enferm Infecc Microbiol Clin 2002; 20: 448-461.
  • 20
    SEIF-88. FIPSE study on liver transplant in HIV-infected patients in Spain. https://www.seif88.com/gesida/asp/login.asp. Accessed August 2011.
  • 21
    Mandell GL, Bennet JE, Dolin R. Mandell, Douglas, and Bennett's Principles and Practice of Infectious Diseases. 7th ed. Philadelphia, PA: Churchill Livingstone; 2010.
  • 22
    Busuttil RW, Klintmalm GK. Transplantation of the Liver. 2nd ed. Philadelphia, PA: Saunders; 2005.
  • 23
    Garner JS, Jarvis WR, Emori TG, Horan TC, Hughes JM. CDC definitions for nosocomial infections, 1988. Am J Infect Control 1988; 16: 128-140.
  • 24
    Aguado JM, Torre-Cisneros J, Fortún J, Benito N, Meije Y, Doblas A, Muñoz P. Consensus document for the management of tuberculosis in solid organ transplant recipients [in Spanish]. Enferm Infecc Microbiol Clin 2009; 27: 465-473.
  • 25
    Benito N, Sued O, Moreno A, Horcajada JP, González J, Navasa M, Rimola A. Diagnosis and treatment of latent tuberculosis infection in liver transplant recipients in an endemic area. Transplantation 2002; 74: 1381-1386.
  • 26
    Ljungman P, Griffiths P, Paya C. Definitions of cytomegalovirus infection and disease in transplant recipients. Clin Infect Dis 2002; 34: 1094-1097.
  • 27
    De Pauw B, Walsh TJ, Donnelly JP, Stevens DA, Edwards JE, Calandra T, et al.; for European Organization for Research and Treatment of Cancer/Invasive Fungal Infections Cooperative Group and National Institute of Allergy and Infectious Diseases Mycoses Study Group Consensus Group. Revised definitions of invasive fungal disease from the European Organization for Research and Treatment of Cancer/Invasive Fungal Infections Cooperative Group and the National Institute of Allergy and Infectious Diseases Mycoses Study Group (EORTC/MSG) Consensus Group. Clin Infect Dis 2008; 46: 1813-1821.
  • 28
    Cervera C, Agustí C, Angeles Marcos M, Pumarola T, Cofán F, Navasa M, et al. Microbiologic features and outcome of pneumonia in transplanted patients. Diagn Microbiol Infect Dis 2006; 55: 47-54.
  • 29
    Wada K, Takada T, Kawarada Y, Nimura Y, Miura F, Yoshida M, et al. Diagnostic criteria and severity assessment of acute cholangitis: Tokyo guidelines. J Hepatobiliary Pancreat Surg 2007; 14: 52-58.
  • 30
    American College of Chest Physicians/Society of Critical Care Medicine consensus conference: definitions for sepsis and organ failure and guidelines for the use of innovative therapies in sepsis. Crit Care Med 1992; 20: 864-874.
  • 31
    Annane D, Bellissant E, Cavaillon JM. Septic shock. Lancet 2005; 365: 63-78.
  • 32
    Ascioglu S, Rex JH, de Pauw B, Bennett JE, Bille J, Crokaert F, et al.; for Invasive Fungal Infections Cooperative Group of the European Organization for Research and Treatment of Cancer and Mycoses Study Group of the National Institute of Allergy and Infectious Diseases. Defining opportunistic invasive fungal infections in immunocompromised patients with cancer and hematopoietic stem cell transplants: an international consensus. Clin Infect Dis 2002; 34: 7-14.
  • 33
    Razonable RR, Zerr DM; for AST Infectious Diseases Community of Practice. HHV-6, HHV-7 and HHV-8 in solid organ transplant recipients. Am J Transplant 2009; 9( suppl 4): S97-S100.
    Direct Link:
  • 34
    Aguado JM, Torre-Cisneros J, Fortún J, Benito N, Meije Y, Doblas A, Muñoz P. Tuberculosis in solid-organ transplant recipients: consensus statement of the group for the study of infection in transplant recipients (GESITRA) of the Spanish Society of Infectious Diseases and Clinical Microbiology. Clin Infect Dis 2009; 48: 1276-1284.
  • 35
    Moreno A, Cervera C, Gavaldá J, Rovira M, de la Cámara R, Jarque I, et al. Bloodstream infections among transplant recipients: results of a nationwide surveillance in Spain. Am J Transplant 2007; 7: 2579-2586.
    Direct Link:
  • 36
    Asensio A, Ramos A, Cuervas-Mons V, Cordero E, Sánchez-Turrión V, Blanes M, et al.; for Red de Estudio de la Infección en el Trasplante and Grupo de Estudio de la Infección en el Trasplante. Effect of antibiotic prophylaxis on the risk of surgical site infection in orthotopic liver transplant. Liver Transpl 2008; 14: 799-805.
    Direct Link:
  • 37
    Griffiths WJ, Wreghitt TG, Alexander GJ. Reactivation of herpes simplex virus after liver transplantation. Transplantation 2005; 80: 1353-1354.
  • 38
    Duchini A, Hendry RM, Redfield DC, Pockros PJ. Influenza infection in patients before and after liver transplantation. Liver Transpl 2000; 6: 531-542.
    Direct Link:
  • 39
    Garrido RS, Aguado JM, Díaz-Pedroche C, Len O, Montejo M, Moreno A, et al. A review of critical periods for opportunistic infection in the new transplantation era. Transplantation 2006; 82: 1457-1462.
  • 40
    Knechtle SJ, Pirsch JD, Fechner JH Jr, Becker BN, Friedl A, Colvin RB, et al. Campath-1H induction plus rapamycin monotherapy for renal transplantation: results of a pilot study. Am J Transplant 2003; 3: 722-730.
    Direct Link:
  • 41
    Peleg AY, Husain S, Kwak EJ, Silveira FP, Ndirangu M, Tran J, et al. Opportunistic infections in 547 organ transplant recipients receiving alemtuzumab, a humanized monoclonal CD-52 antibody. Clin Infect Dis 2007; 44: 204-212.
  • 42
    Pappas PG, Alexander BD, Andes DR, Hadley S, Kauffman CA, Freifeld A, et al. Invasive fungal infections among organ transplant recipients: results of the Transplant-Associated Infection Surveillance Network (TRANSNET). Clin Infect Dis 2010; 50: 1101-1111.
  • 43
    Thin L, Macquillan G, Adams L, Garas G, Seow C, Cannell P, et al. Acute graft-versus-host disease after liver transplant: novel use of etanercept and the role of tumor necrosis factor alpha inhibitors. Liver Transpl 2009; 15: 421-426.
    Direct Link:
  • 44
    Torre-Cisneros J, Doblas A, Aguado JM, San Juan R, Blanes M, Montejo M, et al.; for Spanish Network for Research in Infectious Diseases. Tuberculosis after solid-organ transplant: incidence, risk factors, and clinical characteristics in the RESITRA (Spanish Network of Infection in Transplantation) cohort. Clin Infect Dis 2009; 48: 1657-1665.
  • 45
    Aguilera V, Berenguer M, Rubín A, San-Juan F, Rayón JM, Prieto M, Mir J. Cirrhosis of mixed etiology (hepatitis C virus and alcohol): posttransplantation outcome—comparison with hepatitis C virus-related cirrhosis and alcoholic-related cirrhosis. Liver Transpl 2009; 15: 79-87.
    Direct Link:
  • 46
    Bellier C, Bert F, Durand F, Retout S, Belghiti J, Mentré F, Fantin B. Risk factors for Enterobacteriaceae bacteremia after liver transplantation. Transpl Int 2008; 21: 755-763.
    Direct Link:
  • 47
    Sun HY, Cacciarelli TV, Singh N. Identifying a targeted population at high risk for infections after liver transplantation in the MELD era. Clin Transplant 2011; 25: 420-425.
    Direct Link:
  • 48
    Randomised trial comparing tacrolimus (FK506) and cyclosporin in prevention of liver allograft rejection. European FK506 Multicentre Liver Study Group. Lancet 1994; 344: 423-428.
View Full Article (HTML) Get PDF (492K)